Lyophilization: Why Research Peptides Ship as a Powder

A research peptide almost always arrives as a dry solid in a sealed vial, and not for packaging convenience. Water is a participant in the chemistry that destroys peptides. In solution the backbone is available for hydrolysis and deamidation, and the interfaces a stock meets during handling are where aggregation tends to start. Removing the water does not stop chemistry; it slows the reactions that need water and immobilizes the molecule in a solid matrix. Lyophilization — freeze-drying — is the standard route to that dry solid, because it removes water without ever taking the sample through a warm liquid phase.

Sublimation, and the three steps that are actually happening

Lyophilization is not one operation but three: freezing, primary drying, and secondary drying. In primary drying the chamber pressure is lowered so that ice converts directly to vapor without passing through a liquid phase. That is the sublimation the name refers to, and it is the longest and most critical stage, governed by the coupled transfer of heat into the sublimation front and of vapor out through the layer that has already dried ^[1].

Assegehegn and colleagues mapped shelf temperature, chamber pressure, and vial position onto product temperature, sublimation rate, vial heat transfer coefficient, and the dried product's resistance to mass transfer. At a given product temperature, the highest sublimation rates came from low chamber pressure combined with high shelf temperature; across the shelf, front-edge vials ran to the highest product temperatures and sublimation rates while center vials ran to the lowest ^[1]. A batch is not uniform by default.

Secondary drying is a different mechanism. Once the ice is gone, water that never froze remains sorbed to the solute and is removed by desorption at a higher shelf temperature. This is where most of what is left gets removed, though it is not the only step that determines the cake's final residual moisture.

Freezing decides most of what follows

Kasper and Friess make the case that freezing has historically been the least-optimized and is presumably the most complex step, and that it propagates forward into sample morphology, the physical state of the product, residual moisture content, reconstitution time, and the performance of both drying phases ^[2].

The reason is freeze concentration. As ice crystals grow, everything dissolved is excluded into a shrinking unfrozen fraction, so buffer salts, excipients, and the peptide itself reach concentrations far above their starting values. If one component of a buffer pair crystallizes out of that concentrated phase and the other does not, the pH moves. Gómez and colleagues measured this directly in sodium phosphate: precipitation of disodium hydrogen phosphate dodecahydrate produced abrupt pH decreases beginning after the onset of ice crystallization, between −0.5 and −4.0 °C. From an initial pH of 7.4, the 50 and 100 mM buffers reached 4.2 ± 0.1 at −10 °C, whereas the 8 mM buffer reached only 5.2 ± 0.2 ^[3]. Diluting the buffer reduced the swing; it did not abolish it.

It is tempting to assume such a shift is stamped into the powder; the evidence says otherwise. Vetráková and colleagues compared acidity in aqueous solution, in the frozen state, and in the lyophile using indicator probes. The lyophiles were somewhat changed relative to the starting pH, but the frozen states differed far more, and the large acidification measured on freezing sodium phosphate was no longer detectable once drying was complete. The authors' own reading, and the useful one for a bench researcher: their results suggest that monitoring the final acidity of a lyophile is not sufficient to predict all of the acidity changes that occurred across the process ^[4]. A peptide can pass through a chemical environment the finished powder carries no record of.

The cake is a structure, not a residue

The porous solid left behind is the negative image of the ice that filled the vial. Where ice crystals were, there are now channels; where the freeze-concentrated phase was, the walls between them. That geometry is functional. It is the path vapor travels during primary drying, and the dried layer's resistance to that flow is one of the parameters determining how fast a cycle can run ^[1]. It is also the surface area the diluent must wet later, which is part of why freezing conditions show up as differences in reconstitution time ^[2].

If the product temperature climbs too high during primary drying, the amorphous matrix softens enough that the pore walls can no longer support themselves and the structure sinks — collapse. Cake appearance is conventionally treated as a quality attribute for this reason. Less often stated is how much it predicts about the molecule. Brandstetter and colleagues lyophilized two model fusion-protein formulations using both conservative protocols and aggressive protocols deliberately placed on the verge of structural collapse. The aggressive cycle produced only a minor, formulation-dependent effect on cake volume and particle count, and vial position within the batch did not significantly affect cake appearance, residual moisture, particle burden, or particle morphology ^[6]. That result is specific to those formulations and attributes, and it is no license to ignore a collapsed cake — but it does suggest cake appearance is a coarser signal than it is often treated as.

Residual moisture is never zero, and zero is not the target

A lyophilized cake retains water. The question is how much, and the answer is not "as little as possible." Towns reviewed the effects and measurement of moisture in protein solids: at or below the monolayer level of hydration, degradation is minimal, because water availability is low and the molecule's dynamic activity is limited. Above a monolayer, decomposition rates generally rise, both because the molecule gains conformational flexibility and because the more loosely bound water can mobilize reactants. Water also acts as a plasticizer, lowering the glass transition temperature of the amorphous matrix, so an increase in either temperature or water content can move the solid from a dynamically constrained state to a relaxed one ^[7].

Read literally, that picture sets a floor rather than a slope: it says degradation is minimal at or below a monolayer, not that stability keeps improving as water is driven out below one. The stability data go further than that. Chang and colleagues lyophilized an IgG1 antibody formulated with sucrose or trehalose, alone or mixed with sorbitol, and equilibrated the sucrose systems to residual moistures from below 1% up to 5%. Structural relaxation time fell sharply as water content rose — more mobility, as expected — yet the stability data suggested a minimum in degradation rate at 2%–3% water content rather than at the driest condition, and glass dynamics as measured by that relaxation time could not explain the stability results. The authors raised faster local motions, rather than the global relaxation they measured, as a possibility rather than a finding ^[8]. On that evidence over-drying may be a real failure mode rather than a theoretical one, at least for formulations of this kind, and the mechanism behind the optimum is not settled.

The most instructive pair of studies for peptides is on two hexapeptides differing by one residue. In lyophilized formulations of the Asn-hexapeptide Val-Tyr-Pro-Asn-Gly-Ala, the pH of the bulk solution before freezing had a significant effect on deamidation rate and product distribution, with better solid-state stability in the slightly acidic range of pH 3–5, while residual moisture and temperature proved less significant — and a two-factor interaction indicated that the starting pH set how much stability depended on moisture and temperature at all ^[9]. In the corresponding Asp-hexapeptide, Val-Tyr-Pro-Asp-Gly-Ala, the ranking inverted: the pH of the starting solution was not statistically significant, while residual moisture level, temperature, and — most of all — the type of bulking agent were ^[10].

One substitution, and the formulation variable that dominates changes — though the two designs were not matched: the bulking agent that dominated in the Asp study was not among the factors varied in the Asn study, so the reversal cannot be laid entirely at the door of the single residue. Even so, this is a strong argument against carrying a residual-moisture specification, or a storage assumption, from one peptide to another. A further detail is worth taking from the Asn study: no isoAsp-hexapeptide was detected at pH 5.0 in the solid state, whereas it was the major degradation product in solution ^[9]. The solid state does not merely slow solution chemistry — it can change which products form.

Excipients, and what else is in the vial

Formulated lyophilizates contain more than the active molecule. Bulking agents supply the mass and structure a few milligrams of peptide cannot; sugars such as sucrose and trehalose stay amorphous and form the glassy matrix that holds the molecule still. Whether an excipient crystallizes or stays amorphous is a formulation variable in its own right, and mannitol illustrates why. Hawe and Friess found that sucrose and sodium chloride each inhibited mannitol crystallization during freezing, and that the glass transition temperature of the maximally freeze-concentrated solution was lowered by mannitol and by sodium chloride. Introducing an annealing hold raised mannitol crystallinity, as intended — but it also promoted formation of mannitol hydrate, a species known to convert to anhydrous mannitol polymorphs on storage. Low-temperature X-ray diffraction placed the hydrate's formation below −30 °C and not at −27 °C ^[5]. A processing choice made in an afternoon seeded a solid-state change that plays out later in the vial, on a storage timescale the study does not put a number on.

Excipients also decide where the water sits: Towns noted that excipient selection has a large effect on water–protein interactions, because small ions and the crystallization of excipients can redistribute the water available to the protein ^[7].

Many research peptide vials are not formulated this way at all. They contain the peptide, its counter-ion, and residual water — no bulking agent, no sugar. That is a legitimate choice for material that will be dissolved soon after purchase, but it means the cake can be thin, filmy, or barely visible, and none of the protective mechanisms above are present. What is in a given vial is a question for that lot's certificate of analysis, not an assumption.

What the number on the label weighs

A vial labeled 10 mg does not contain 10 mg of peptide. Peptides made by solid-phase synthesis are routinely isolated as trifluoroacetate salts, because trifluoroacetic acid serves as both cleavage agent and ion-pairing reagent during purification ^[12]. Erckes and colleagues exchanged that counter-ion for chloride by freeze-drying from hydrochloric acid, quantified residual trifluoroacetate by FT-IR, fluorine-19 NMR, and HPLC with evaporative light-scattering detection, and found 10 mM HCl optimal with no impact on peptide purity at any concentration tested. Passive permeability coefficients in a liposomal fluorescence assay differed with both sequence and salt form, which is the basis for their argument that counter-ion content should be quantified and specified rather than assumed ^[12].

The arithmetic is worth doing explicitly. Take a nominal 10 mg vial whose certificate of analysis reports 82.0% peptide content by weight. The peptide mass is 10 mg × 0.820 = 8.20 mg. Reconstituting in 2.00 mL gives 8.20 mg ÷ 2.00 mL = 4.10 mg/mL. Dividing the label instead gives 5.00 mg/mL. The ratio 4.10 ÷ 5.00 = 0.82, so the label-derived figure is high by 22%: 5.00 ÷ 4.10 = 1.22, which is just 1 ÷ 0.82, the reciprocal of the peptide content.

Two terms of mass separate the label from the peptide:

• Counter-ion mass. Usually the larger of the two. Peptide content does not isolate it: that figure is the fraction of vial weight that is peptide, so counter-ion, residual water, and any residual salts sit inside the remainder together.
• Residual water. If a cake weighs 12.0 mg and Karl Fischer titration reports 2.5% w/w water, the water contributes 12.0 mg × 0.025 = 0.30 mg. Small, but it is the term that changes: the powder is hygroscopic, and a vial left open in humid air is no longer the vial that was analyzed. Accurate moisture determination depends heavily on sample handling that keeps atmospheric moisture out ^[7].

A third term is geometric rather than chemical: the cake occupies space, so adding 2 mL of diluent yields slightly more than 2 mL of solution, a small but systematic bias that always makes the calculated concentration read high. That arithmetic needs the peptide content from the correct lot.

What reconstitution restores, and what it does not

Adding diluent restores solvation and mobility. It does not restore covalent structure: deamidation, isomerization, and oxidation that occurred in the solid state are changes to bonds, and dissolving the powder does not reverse them. Whatever the cake was when the solvent went in is what the solution is.

Nor is reconstitution a neutral step. Traub-Hoffmann and colleagues compared standardized mechanical protocols against a manual one for a bispecific antibody lyophilizate. The automated protocols cut reconstitution time from 25 minutes to under 5, but the more consequential result was that monomer content and subvisible particle formation differed considerably between protocols, leading them to conclude that the reconstitution protocol influences the stability of sensitive proteins ^[11]. Their subject was a large protein; how much a short synthetic peptide cares about the way diluent enters the vial has not been characterized to a comparable standard, and treating the answer as "not at all" is an assumption rather than a finding.

Finally, a clear solution is not evidence of an intact molecule. Dissolution is a physical observation; whether the material is the intended sequence at the stated purity is answered by chromatography and mass spectrometry on that lot. Our companion guide on reconstitution and handling covers the bench procedure itself.

Separating what is measured from what is convention

Much of what surrounds a lyophilized vial is well measured: sublimation rates and the transfer coefficients governing them ^[1], freezing-induced pH shifts in phosphate, measured in situ with salt crystallization confirmed by X-ray diffraction ^[3], a residual-moisture optimum suggested by the stability data for particular protein formulations ^[8], the windows in which mannitol hydrate forms ^[5], and the relative weight of formulation variables for specific model peptides ^{[9, 10]}. Other widely repeated practices are convention with thin primary literature behind them, at least for short synthetic peptides:

• Equilibrating a cold vial to room temperature before opening it, so atmospheric moisture does not condense onto a hygroscopic solid.
• Storing dry material at −20 °C rather than at some other temperature.
• Directing diluent down the vial wall instead of onto the cake, and not vortexing.
• Reading cake appearance as a proxy for product quality.

Each is sensible and near-universal. They are also, for this class of material, largely inherited from protein formulation practice rather than demonstrated on the compounds in question.

And some things are simply not known. Sequence-specific residual moisture specifications do not exist for most research peptides. Whether solid-state product distributions measured on model hexapeptides generalize to longer or modified sequences has not been tested broadly, nor has the contribution of vial headspace and closure over months at research scale. The honest position: the dry state buys a large, well-documented stability advantage over solution, the size of that advantage is sequence-dependent, and the specific number for any given peptide is usually an extrapolation rather than a measurement.

What follows is modest: record the lot, the peptide content used in the calculation, the diluent and its volume, and the date. Those four values let a result months later be attributed to the biology rather than to the powder. For laboratory research use only.